1 |
dpavlin |
1.1 |
<p><b>Product List</b></p> |
2 |
|
|
<p><font color="#CC6633"><b>Active Pharmaceutical Ingredients and Intermediates</b></font></p> |
3 |
|
|
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
4 |
|
|
<tr bgcolor="#ECF5FF"> |
5 |
|
|
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">DIURETICS</b></font></td> |
6 |
|
|
</tr> |
7 |
|
|
</table> |
8 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
9 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
10 |
|
|
<tr> |
11 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
12 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">CHLOROTHIAZIDE</font></b></font></td> |
13 |
|
|
<td width="285"> </td> |
14 |
|
|
</tr> |
15 |
|
|
<tr> |
16 |
|
|
<td width="35"> </td> |
17 |
|
|
<td width="180"><font color="#000099">EP, USP</font></td> |
18 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
19 |
|
|
</tr> |
20 |
|
|
<tr> |
21 |
|
|
<td width="35"> </td> |
22 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1982 / FDA-DMF No.4610 |
23 |
|
|
; submitted in US only </font></td> |
24 |
|
|
</tr> |
25 |
|
|
</table> |
26 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
27 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
28 |
|
|
<tr> |
29 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
30 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">CHLORTHALIDONE</font></b></font></td> |
31 |
|
|
<td width="285"> </td> |
32 |
|
|
</tr> |
33 |
|
|
<tr> |
34 |
|
|
<td width="35"> </td> |
35 |
|
|
<td width="180"><font color="#000099">EP, BP, USP</font></td> |
36 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
37 |
|
|
</tr> |
38 |
|
|
<tr> |
39 |
|
|
<td width="35"> </td> |
40 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1983 / FDA-DMF No.5104 |
41 |
|
|
; submitted in 6 countries </font></td> |
42 |
|
|
</tr> |
43 |
|
|
</table> |
44 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
45 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
46 |
|
|
<tr> |
47 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
48 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">HYDROCHLOROTHIAZIDE</font></b></font></td> |
49 |
|
|
<td width="285"> </td> |
50 |
|
|
</tr> |
51 |
|
|
<tr> |
52 |
|
|
<td width="35"> </td> |
53 |
|
|
<td width="180"><font color="#000099">EP, BP, USP, DAB</font></td> |
54 |
|
|
<td width="285"><font color="#336699">40 kg drum, 50 kg drum</font></td> |
55 |
|
|
</tr> |
56 |
|
|
<tr> |
57 |
|
|
<td width="35"> </td> |
58 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1981 / FDA-DMF No.4028 |
59 |
|
|
; submitted in 26 countries </font></td> |
60 |
|
|
</tr> |
61 |
|
|
</table> |
62 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
63 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
64 |
|
|
<tr bgcolor="#ECF5FF"> |
65 |
|
|
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">SULFONAMIDES</b></font></td> |
66 |
|
|
</tr> |
67 |
|
|
</table> |
68 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
69 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
70 |
|
|
<tr> |
71 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
72 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">SULFAMETHOXAZOLE</font></b></font></td> |
73 |
|
|
<td width="285"> </td> |
74 |
|
|
</tr> |
75 |
|
|
<tr> |
76 |
|
|
<td width="35"> </td> |
77 |
|
|
<td width="180"><font color="#000099">EP, USP</font></td> |
78 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
79 |
|
|
</tr> |
80 |
|
|
<tr> |
81 |
|
|
<td width="35"> </td> |
82 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1982 / FDA-DMF No.4291 |
83 |
|
|
; submitted in 6 countries </font></td> |
84 |
|
|
</tr> |
85 |
|
|
</table> |
86 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
87 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
88 |
|
|
<tr> |
89 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
90 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">SULFISOXAZOLE |
91 |
|
|
(SULPHAFURAZOLE)</font></b></font></td> |
92 |
|
|
</tr> |
93 |
|
|
<tr> |
94 |
|
|
<td width="35"> </td> |
95 |
|
|
<td width="180"><font color="#000099">BP, USP</font></td> |
96 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
97 |
|
|
</tr> |
98 |
|
|
<tr> |
99 |
|
|
<td width="35"> </td> |
100 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1976 / FDA-DMF No.2739 |
101 |
|
|
; submitted in 3 countries </font></td> |
102 |
|
|
</tr> |
103 |
|
|
</table> |
104 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
105 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
106 |
|
|
<tr> |
107 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
108 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">SULFISOXAZOLE |
109 |
|
|
ACETYL </font></b></font></td> |
110 |
|
|
</tr> |
111 |
|
|
<tr> |
112 |
|
|
<td width="35"> </td> |
113 |
|
|
<td width="180"><font color="#000099">USP</font></td> |
114 |
|
|
<td width="285"><font color="#336699">30 kg drum, 50 kg drum</font></td> |
115 |
|
|
</tr> |
116 |
|
|
<tr> |
117 |
|
|
<td width="35"> </td> |
118 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1981 / FDA-DMF No.4040 |
119 |
|
|
; submitted in 4 countries</font></td> |
120 |
|
|
</tr> |
121 |
|
|
</table> |
122 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
123 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
124 |
|
|
<tr bgcolor="#ECF5FF"> |
125 |
|
|
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">ANTIBIOTICS</b></font></td> |
126 |
|
|
</tr> |
127 |
|
|
</table> |
128 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
129 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
130 |
|
|
<tr> |
131 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
132 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">OXYTETRACYCLINE |
133 |
|
|
DIHYDRATE</font></b></font></td> |
134 |
|
|
</tr> |
135 |
|
|
<tr> |
136 |
|
|
<td width="35"> </td> |
137 |
|
|
<td width="180"><font color="#000099">EP, USP</font></td> |
138 |
|
|
<td width="285"><font color="#336699">25 kg drum </font></td> |
139 |
|
|
</tr> |
140 |
|
|
<tr> |
141 |
|
|
<td width="35"> </td> |
142 |
|
|
<td colspan="2"><font color="#000099">AADA/DMF: in US since 1966 / FDA-DMF |
143 |
|
|
No.61-236 ; submitted in 17 countries</font></td> |
144 |
|
|
</tr> |
145 |
|
|
</table> |
146 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
147 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
148 |
|
|
<tr> |
149 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
150 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">OXYTETRACYCLINE |
151 |
|
|
HYDROCHLORIDE</font></b></font></td> |
152 |
|
|
</tr> |
153 |
|
|
<tr> |
154 |
|
|
<td width="35"> </td> |
155 |
|
|
<td width="180"><font color="#000099">EP, USP</font></td> |
156 |
|
|
<td width="285"><font color="#336699">25 kg drum</font></td> |
157 |
|
|
</tr> |
158 |
|
|
<tr> |
159 |
|
|
<td width="35"> </td> |
160 |
|
|
<td colspan="2"><font color="#000099">AADA/DMF: in US since 1966 / FDA-DMF |
161 |
|
|
No.61-235 ; submitted in 12 countries</font></td> |
162 |
|
|
</tr> |
163 |
|
|
</table> |
164 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
165 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
166 |
|
|
<tr> |
167 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
168 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">MUPIROCIN</font></b></font></td> |
169 |
|
|
<td width="285"> </td> |
170 |
|
|
</tr> |
171 |
|
|
<tr> |
172 |
|
|
<td width="35"> </td> |
173 |
|
|
<td width="180"><font color="#000099">USP </font></td> |
174 |
|
|
<td width="285"> </td> |
175 |
|
|
</tr> |
176 |
|
|
<tr> |
177 |
|
|
<td width="35"> </td> |
178 |
|
|
<td colspan="2"><font color="#000099">Packing: upon request</font></td> |
179 |
|
|
</tr> |
180 |
|
|
</table> |
181 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
182 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
183 |
|
|
<tr bgcolor="#ECF5FF"> |
184 |
|
|
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">VARIOUS |
185 |
|
|
ACTIVE PHARMACEUTICAL INGREDIENTS </b></font></td> |
186 |
|
|
</tr> |
187 |
|
|
</table> |
188 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
189 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
190 |
|
|
<tr> |
191 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
192 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">ACETAZOLAMIDE</font></b></font></td> |
193 |
|
|
<td width="285"> </td> |
194 |
|
|
</tr> |
195 |
|
|
<tr> |
196 |
|
|
<td width="35"> </td> |
197 |
|
|
<td width="180"><font color="#000099">BP, USP</font></td> |
198 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
199 |
|
|
</tr> |
200 |
|
|
<tr> |
201 |
|
|
<td width="35"> </td> |
202 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1977 / FDA-DMF No.2833 |
203 |
|
|
; submitted in 20 countries </font></td> |
204 |
|
|
</tr> |
205 |
|
|
</table> |
206 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
207 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
208 |
|
|
<tr> |
209 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
210 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">MESALAZINE</font></b></font></td> |
211 |
|
|
<td width="285"> </td> |
212 |
|
|
</tr> |
213 |
|
|
<tr> |
214 |
|
|
<td width="35"> </td> |
215 |
|
|
<td width="180"><font color="#000099">USP</font></td> |
216 |
|
|
<td width="285"><font color="#336699">20 kg drum</font></td> |
217 |
|
|
</tr> |
218 |
|
|
<tr> |
219 |
|
|
<td width="35"> </td> |
220 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1994 / FDA-DMF No.11280 |
221 |
|
|
; submitted in 5 countries </font></td> |
222 |
|
|
</tr> |
223 |
|
|
</table> |
224 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
225 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
226 |
|
|
<tr> |
227 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
228 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">PEMOLINE</font></b> |
229 |
|
|
</font></td> |
230 |
|
|
<td width="285"> </td> |
231 |
|
|
</tr> |
232 |
|
|
<tr> |
233 |
|
|
<td width="35"> </td> |
234 |
|
|
<td width="180"><font color="#000099">PLIVAspecifications</font></td> |
235 |
|
|
<td width="285"><font color="#336699">50 kg drum</font></td> |
236 |
|
|
</tr> |
237 |
|
|
<tr> |
238 |
|
|
<td width="35"> </td> |
239 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1999 / FDA-DMF No.13919 |
240 |
|
|
; submitted in US only </font></td> |
241 |
|
|
</tr> |
242 |
|
|
</table> |
243 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
244 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
245 |
|
|
<tr> |
246 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
247 |
|
|
<td width="180"><font color="#003300"><b><font color="#000066">KETOPROFEN</font></b></font></td> |
248 |
|
|
<td width="285"> </td> |
249 |
|
|
</tr> |
250 |
|
|
<tr> |
251 |
|
|
<td width="35"> </td> |
252 |
|
|
<td width="180"><font color="#000099">EP, USP</font></td> |
253 |
|
|
<td width="285"><font color="#336699">25 kg drum</font></td> |
254 |
|
|
</tr> |
255 |
|
|
<tr> |
256 |
|
|
<td width="35"> </td> |
257 |
|
|
<td colspan="2"><font color="#000099">DMF: in US since 1990 / FDA - DMF No. |
258 |
|
|
8551 ; submitted in US only</font></td> |
259 |
|
|
</tr> |
260 |
|
|
</table> |
261 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
262 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
263 |
|
|
<tr bgcolor="#ECF5FF"> |
264 |
|
|
<td height="20"><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">INTERMEDIATES</b></font></td> |
265 |
|
|
</tr> |
266 |
|
|
</table> |
267 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
268 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
269 |
|
|
<tr> |
270 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
271 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">5-ACETYLSALICYLAMIDE</font></b></font></td> |
272 |
|
|
</tr> |
273 |
|
|
<tr> |
274 |
|
|
<td width="35"> </td> |
275 |
|
|
<td width="180"><font color="#000099">PLIVA specifications</font></td> |
276 |
|
|
<td width="285"><font color="#336699">25 kg drum </font></td> |
277 |
|
|
</tr> |
278 |
|
|
</table> |
279 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
280 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
281 |
|
|
<tr> |
282 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
283 |
|
|
<td colspan="2"><font color="#000099"><b><font color="#000066">MONOACETONEGLUCOSE |
284 |
|
|
</font> </b></font></td> |
285 |
|
|
</tr> |
286 |
|
|
<tr> |
287 |
|
|
<td width="35"> </td> |
288 |
|
|
<td width="180"><font color="#000099">PLIVA specifications</font></td> |
289 |
|
|
<td width="285"><font color="#336699">30 kg drum</font></td> |
290 |
|
|
</tr> |
291 |
|
|
</table> |
292 |
dpavlin |
1.2 |
<img src="t/n.gif" width="8" height="10"> |
293 |
dpavlin |
1.1 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
294 |
|
|
<tr> |
295 |
|
|
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
296 |
|
|
<td colspan="2"><font color="#003300"><b><font color="#000066">DIACETONEGLUCOSE</font></b></font></td> |
297 |
|
|
</tr> |
298 |
|
|
<tr> |
299 |
|
|
<td width="35"> </td> |
300 |
|
|
<td width="180"><font color="#000099">PLIVA specifications</font></td> |
301 |
|
|
<td width="285"><font color="#336699">30 kg drum</font></td> |
302 |
|
|
</tr> |
303 |
|
|
</table> |
304 |
|
|
<p> Products are in accordance with current EP and with national pharmacopeias |
305 |
|
|
such as BP, USP and DAB.</p> |